Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial

INTRODUCTION: Radiation-induced lung injury (RILI) is one of the most clinically-challenging toxicities and dose-limiting factors during and/or after thoracic radiation therapy for oesophageal squamous cell carcinoma (ESCC). With limited effective protective drugs against RILI, the main strategy to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Zeng, Bangwei, Xue, Dan, Cao, Rongxiang, Liao, Siqin, Yang, Yong, Li, Zhihua, Kang, Mingqiang, Chen, Chun, Xu, Benhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621153/
https://www.ncbi.nlm.nih.gov/pubmed/36302570
http://dx.doi.org/10.1136/bmjopen-2021-060619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621153/
https://www.ncbi.nlm.nih.gov/pubmed/36302570
http://dx.doi.org/10.1136/bmjopen-2021-060619

Ejemplares similares